Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges (2022)
Attributed to:
Centre for Musculoskeletal Ageing Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.20944/preprints202212.0079.v1
Publication URI: http://dx.doi.org/10.20944/preprints202212.0079.v1
Type: Preprint